ArticleEuropean urology oncology2021

A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.

Ali Raza Khaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.